OBJECTIVE 1: Recognize clinical criteria for diagnosing Lipedema.

Which of the following is NOT a common symptom of Lipedema?

How well did this activity meet Learning Objective 1 (To recognize clinical criteria for diagnosing Lipedema)?

Learning Objective 1 (To recognize clinical criteria for diagnosing Lipedema) will increase/improve my:

OBJECTIVE 2: Differentiate between Lipedema, Lymphedema, and General Obesity, as these conditions are distinct but may co-exist.

Which of the following statements regarding Lymphedema and Lipedema is true?

How well did this activity meet Learning Objective 2 (To differentiate between Lipedema, Lymphedema, and General Obesity)?

Learning Objective 2 (To differentiate between Lipedema, Lymphedema, and General Obesity) will increase/improve my:

OBJECTIVE 3: Understand the role of lymphoscintigraphy, magnetic resonance lymphangiography, and indocyanine green fluorescent lymphangiography in differentiating Lipedema from Lymphedema.

Lipedema is usually associated with abnormal lymposcintigraphy and ICG lymphangiography. True or False?

How well did this activity meet Learning Objective 3 (To understand the role of lymphoscintigraphy, magnetic resonance lymphangiography, and indocyanine green fluorescent lymphangiography in differentiating Lipedema from Lymphedema)?

Learning Objective 3 (To understand the role of lymphoscintigraphy, magnetic resonance lymphangiography, and indocyanine green fluorescent lymphangiography in differentiating Lipedema from Lymphedema) will increase/improve my:

OBJECTIVE 4: Describe surgical and non-surgical Lipedema treatments, including liposuction, manual lymphatic decompression, bandaging, and compression garments, and compare the limitations of each treatment modality.

Treatment for Lipedema includes:

How well did this activity meet Learning Objective 4 (To describe surgical and non-surgical Lipedema treatments, including liposuction, manual lymphatic decompression, bandaging, and compression garments, and compare the limitations of each treatment modality)?

Learning Objective 4 (To describe surgical and non-surgical Lipedema treatments, including liposuction, manual lymphatic decompression, bandaging, and compression garments, and compare the limitations of each treatment modality) will increase/improve my:

OBJECTIVE 5: Explain what is known about Lipedema regarding etiology and disease progression.

Which of the following is known to cause Lipedema?

How well did this activity meet Learning Objective 5 (To explain what is known about Lipedema regarding etiology and disease progression)?

Learning Objective 5 (To explain what is known about Lipedema regarding etiology and disease progression) will increase/improve my:

OBJECTIVE 6: Describe the stages of Lipedema, including progression to Lipo-Lymphedema.

Stage 3 Lipedema includes:

How well did this activity meet Learning Objective 6 (To describe the stages of Lipedema, including progression to Lipo-Lymphedema)?

Learning Objective 6 (To describe the stages of Lipedema, including progression to Lipo-Lymphedema) will increase/improve my:

OBJECTIVE 7: Assess the relationship of Lipedema to venous, bariatric, and orthopedic conditions including venous insufficiency, weight gain, and gait disturbances.

Which of the following is NOT true?

How well did this activity meet Learning Objective 7 (To assess the relationship of Lipedema to venous, bariatric, and orthopedic conditions including venous insufficiency, weight gain, and gait disturbances)?

Learning Objective 7 (To assess the relationship of Lipedema to venous, bariatric, and orthopedic conditions including venous insufficiency, weight gain, and gait disturbances) will increase/improve my:

OBJECTIVE 8: Examine the current understanding of inflammatory, genetic, metabolic, and endocrine influences on fat deposition, the knowledge gaps in relation to Lipedema, obstacles to patient care, and the potential opportunities for further research.

Current theories regarding the cause of Lipedema include:

How well did this activity meet Learning Objective 8 (To examine the current understanding of inflammatory, genetic, metabolic, and endocrine influences on fat deposition, the knowledge gaps in relation to Lipedema, obstacles to patient care, and the potential opportunities for further research)?

Learning Objective 8 (To examine the current understanding of inflammatory, genetic, metabolic, and endocrine influences on fat deposition, the knowledge gaps in relation to Lipedema, obstacles to patient care, and the potential opportunities for further research) will increase/improve my:

Please indicate which of the following American Board of Medical Specialties/Institute of Medicine core competencies were addressed by this educational activity (select all that apply):

The content of this activity matched my current (or potential) scope of practice.

Was this activity scientifically sound and free of commercial bias (defined as a personal judgment in favor of a specific product or service of a commercial interest) or influence?

To what extent do you agree with the following statement?

I expect that this educational activity will enhance my professional effectiveness in treating patients.

To what extent do you agree with the following statement?

This educational activity will result in a change in my practice behavior.

Please indicate any barriers you perceive in implementing these changes.

If you indicated any barriers, how will you address these barriers in order to implement changes in your knowledge, competency, performance, and/or patients’ outcomes?

May we contact you via e-mail for a 2-3 month, post-activity outcomes survey?

In comparison to other similar activities, how would you rate this one?

Please share any comments you have about this activity.

Thank you for your participation.

For Physicians:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Mount Sinai Beth Israel and The Friedman Center for Lymphedema Research & Treatment. Mount Sinai Health System Hospital: Beth Israel, Mount Sinai St. Luke’s and Mount Sinai West are accredited by the ACCME to provide continuing medical education for physicians.

Mount Sinai Beth Israel designates this enduring material for a maximum of 5.50 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

To assist with future planning please answer the following:

• I attest to time spent on activity, I participated in the activity and claim the following number of CME Credits:

I spent the following number of hours (to the closest 1/2 hour) on this program: